About Peptides

A 15-amino-acid peptide derived from a protein found in gastric juice. Studied in preclinical models for soft-tissue and gut-lining repair, angiogenesis, and cytoprotective signalling.

A two-peptide blend. CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog; Ipamorelin is a selective ghrelin-receptor agonist. The two are commonly paired in research examining pulsatile growth hormone release.

A copper-binding tripeptide (glycyl-histidyl-lysine) complexed with copper. Studied for roles in skin remodelling, collagen synthesis and wound repair. Also one of the four components of the KLOW blend.

A selective growth hormone secretagogue acting on the ghrelin receptor (GHS-R1a). Noted in research models for stimulating GH release with comparatively little effect on cortisol and prolactin.

A four-peptide blend: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg). Investigated for overlapping roles in tissue remodelling, wound-healing and inflammation pathways.

A mitochondrial-derived peptide. Studied for its role in metabolic regulation, AMPK signalling, and insulin sensitivity in laboratory models.

Nicotinamide adenine dinucleotide — a coenzyme found in all living cells rather than a peptide. Central to cellular energy metabolism, sirtuin activity and DNA-repair research.

Also written Pinealon — a short tripeptide (Glu-Asp-Arg) from the Khavinson family of peptide bioregulators. Studied in research models for effects on neuronal cells and gene expression in brain tissue.

An investigational triple receptor agonist targeting the GLP-1, GIP and glucagon receptors. Currently under study in clinical trials for metabolic and body-weight regulation. Not an approved medicine.

A synthetic analog of the immune peptide tuftsin. Investigated in animal models for anxiolytic and cognitive effects, and for its influence on GABA and BDNF signalling.

A synthetic peptide based on a fragment of ACTH (4–10). Studied for neuroprotective and cognitive effects and for its influence on BDNF expression in research models.

Also known as elamipretide — a mitochondria-targeting tetrapeptide that binds cardiolipin in the inner mitochondrial membrane. Investigated in clinical research for mitochondrial function and related disorders.

A stabilised GHRH analog. Approved under the brand name Egrifta for HIV-associated lipodystrophy, and studied more broadly for its effects on visceral adipose tissue and IGF-1.

A 28-amino-acid peptide derived from prothymosin alpha. Marketed in some countries as Zadaxin for hepatitis B and studied for its role in T-cell maturation and immune signalling.